Ingram Micro Commerce & Lifecycle Services Adds Shipwire Logistics Platform to Sweden Warehouse
18.8.2021 07:00:00 EEST | Business Wire | Press release
Ingram Micro Commerce & Lifecycle Services, a leading provider of e-commerce fulfillment solutions and third-party logistics, today announced that Shipwire, the company’s e-commerce logistics platform, has been integrated into its warehouse in Borås, Sweden. Access to Shipwire enables online brands and retailers in the region to manage their operations through the cloud-based platform and ship to customers domestically and internationally.
Ingram Micro’s Shipwire-integrated warehouse in Borås is strategically located 63km from the Port of Gothenburg, the largest port in the Nordics, and 41km from the Gothenburg-Landvetter Airport. Additionally, its location along Route 40 between Gothenburg and Jönköpings makes Borås an important logistics hub within the region. Current clients are using the facility to ship domestically, regionally and overseas.
“With Shipwire newly available in our warehouse in Sweden, we are excited to offer our customers the opportunity to leverage the platform for e-commerce fulfillment throughout Europe,” said Marcelo Wesseler, vice president of e-commerce, Ingram Micro Commerce & Lifecycle Services. “Along with our operational capabilities in Sweden, we recently opened a new office in Berlin, a technology hub for Europe, and we look forward to building upon our legacy of serving Europe’s top e-commerce brands and retailers.”
E-commerce in the Nordics continues to grow and benefits from an economically strong consumer market. The region also boasts one of the most connected populations in the world, with Internet penetration at 94.5%, according to the World Bank. Ingram Micro has one other warehouse located in Sweden and its global network includes over 120 facilities.
About Ingram Micro Commerce & Lifecycle Services
Ingram Micro Commerce & Lifecycle Services provides global supply chain solutions that connect supply and demand. From cross-border fulfillment to dropship and returns management, IT asset disposition, re-marketing, distribution and more, our solutions drive growth across the commerce and technology markets. The company proudly serves customers ranging from fast-growing brands to Global 2000 enterprises and are dedicated to facilitating their success through our global warehousing network, world-class technology, strategic partnerships, and decades of experience. Learn more at www.ingrammicroservices.com.
About Shipwire
Shipwire, a cloud-based platform from Ingram Micro Commerce & Lifecycle Services, offers a comprehensive order management system that connects merchants to an expansive global network of warehouses, parcel carriers, transportation and ecommerce options. The platform’s logistics infrastructure supports B2B and B2C solutions and enables fast order fulfillment, inventory control and visibility, and optimized supply chain solutions. For more information, contact Shipwire at: www.shipwire.com/contact/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005929/en/
Contact information
Press Contact
Lauren Jow
Global Brand Manager
Ingram Micro Commerce & Lifecycle Services
lauren.jow@ingrammicro.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy8.6.2026 09:00:00 EEST | Press release
Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared. "PlanOne™ began with listening. Over the years, our work on control systems in radiation oncology has put us in direct, ongoing contact with medical physicists and clinical teams at some of the leading facilities in the world," said Mark Pleško, CEO of Cosylab. "Our partners have been clear on what matters most for particle therapy: physics accuracy they can defend, clinical confidence at the point of plan approval, and a platform built to grow with AI and adaptive workflows. We designed PlanOne™ around those three priorities, and we'll keep developing it together with the clinical community that helped shape it." Physics-accurate, radiobiologically informed planning PlanOne™ is built on a GPU-accelerated Monte Carlo dose engin
BitGo MENA Launches Regulated Electronic Trading, Delivering Full Suite Trading Services to the Region8.6.2026 07:00:00 EEST | Press release
BitGo MENA FZE (“BitGo MENA”), a subsidiary of BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo”), the digital asset infrastructure company, today announced the launch of electronic trading in the Middle East and North African (MENA). With this launch, clients can now access a comprehensive trading solution combining BitGo MENA’s established over-the-counter (OTC) trading offering with institutional-grade electronic execution, all operating under BitGo MENA’s Broker-Dealer license from Dubai’s Virtual Assets Regulatory Authority (VARA). The launch further expands BitGo MENA’s regulated product suite under VARA’s oversight, marking another step in the region’s continued buildout of institutional digital asset infrastructure amid growing demand for integrated execution and custody solutions. “The Middle East and North Africa has quickly become one of the most exciting regions in the world for digital assets, with regulators, institutions, and innovators moving with real purpose,” said Mike Bels
Vertex Presents New Data on ALYFTREK ® at European Cystic Fibrosis Conference5.6.2026 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cystic Fibrosis Conference, show children ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including those who are homozygous for the F508del mutation (F/F) and those who have F508del/minimal function mutations (F/MF)on ALYFTREK had further improvement in CFTR function from a TRIKAFTA ® baseline as measured by sweat chloride (SwCl), with 65% having achieved SwCl <30 mmol/L after treatment with ALYFTREK. Vertex also presented Phase 3 data of children ages 1 to <2 with TRIKAF
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 14:00:00 EEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 13:41:00 EEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom